Assessing Pain Linked to High Metabolic and Glycolytic Shift in Neurofibromatosis Type 1 (NF1) Patients by Using a Bioenergetic Biomarker: A Pilot Study.
Miller GP, Krager K, Eom D, Aykin-Burns N, Santos-Horta E.
Cureus. 2026
TGF-β Is Critical for Ovarian Cancer Migration, Invasion, and Chemosensitivity.
Elms C, Wei W, Birrer MJ.
Cancers (Basel).
Bioactivation and reactivity research advances – 2025 year in review.
Liu J, Argikar UA, Brunetti P, Chatzopoulou M, Cho S, Claesson A, Dhaware D, Lang J, Ma B, Ma S, Maw H, Miller GP, Schadt S, Seneviratne HK, Tang LWT, Wei C, Khojasteh SC.
Drug Metab Rev. 2026
Dynamic global acetylation remodeling during the yeast heat shock response.
Hardman-Kavanaugh RE, Storey AJ, Stuecker TN, Hood SE, Barrett-Wilt GA, Krishnamurthi VR, Wang Y, Byrum SD, Mackintosh SG, Edmondson RD, Wahls WP, Tackett AJ, Lewis JA.
Genome Biol. 2026
The nucleoside analog CMX521 inhibits coronavirus RNA-dependent RNA polymerase via a two-pronged mechanism.
Rakib A, Gordon C, Anderson TK, Marecki JC, Smitskamp Q, Moorman NJ, Heise MT, Colton HM, Selleseth D, Lanier ER, Raney KD, Kirchdoerfer RN, Götte M, Dulin D.
bioRxiv [Preprint]. 2026
A peptide-based screen for cell death inhibitors identifies the cytoprotective compound CDL36.
Inde Z, Keppler S, Gelles J, Fraser CS, Presser A, Mohammed JN, Jung M, Garvey DS, Moldoveanu T, Chipuk JE, Sarosiek KA.
bioRxiv [Preprint]. 2026